Andrew Elvington
Impact in
- Neurology top 5%
- Neuroinflammation and Neurodegeneration Mechanisms
- Immunology top 10%
- Atherosclerosis and Cardiovascular Diseases
- Complement system in diseases
- Immune cells in cancer
Papers in
- Immunology 10
- Atherosclerosis and Cardiovascular Diseases 6
- Complement system in diseases 3
- Immune cells in cancer 3
-
- Neuroinflammation and Neurodegeneration Mechanisms 4
- Co-authors
- Stephen Tomlinson (5 shared papers)Gwendalyn J. Randolph (11 shared papers)Ali Alawieh (2 shared papers)Carl Atkinson (4 shared papers)Mark S. Kindy (3 shared papers)Li‐Hao Huang (2 shared papers)Jin Yu (2 shared papers)Jesse W. Williams (5 shared papers)
- Journals
- The Journal of Immunology (3 papers)Arteriosclerosis Thrombosis and Vascular Biology (2 papers)Frontiers in Immunology (2 papers)Frontiers in Pharmacology (1 paper)Journal of Neuroinflammation (1 paper)
- Partner nations
- United StatesGermanyChina
In The Last Decade
Andrew Elvington
16 papers receiving 786 citations
Peers
Comparison fields: 5 of 76
- Neurology 147
- Immunology 365
- Transplantation 14
- Biological Psychiatry 12
- Epidemiology 141
Countries citing papers authored by Andrew Elvington
This map shows the geographic impact of Andrew Elvington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Elvington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Elvington more than expected).
Fields of papers citing papers by Andrew Elvington
This network shows the impact of papers produced by Andrew Elvington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Elvington. The network helps show where Andrew Elvington may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Elvington, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 147 | |
| 2 | 2015 | 82 | |
| 3 | 2012 | 76 | |
| 4 | 2015 | 74 | |
| 5 | 2015 | 69 | |
| 6 | 2011 | 59 | |
| 7 | 2018 | 43 | |
| 8 | 2009 | 41 | |
| 9 | 2018 | 38 | |
| 10 | 2016 | 38 | |
| 11 | 2017 | 35 | |
| 12 | 2021 | 26 | |
| 13 | 2018 | 23 | |
| 14 | 2020 | 16 | |
| 15 | 2019 | 13 | |
| 16 | 2016 | 13 |
About Andrew Elvington
Andrew Elvington is a scholar working on Immunology, Neurology, Oncology, Surgery and Molecular Biology, having authored 16 papers that have together received 793 indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers), Complement system in diseases (3 papers), Immune cells in cancer (3 papers), Chemokine receptors and signaling (2 papers), Cell Adhesion Molecules Research (2 papers), Adipose Tissue and Metabolism (1 paper) and Parasites and Host Interactions (1 paper). The work is most often cited by research in Neurology (147 citations), Immunology (365 citations), Transplantation (14 citations), Biological Psychiatry (12 citations) and Epidemiology (141 citations). Andrew Elvington has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Stephen Tomlinson, Gwendalyn J. Randolph, Ali Alawieh, Carl Atkinson, Mark S. Kindy, Li‐Hao Huang, Jin Yu, Jesse W. Williams, Brian T. Saunders and Bernd H. Zinselmeyer. Their work appears in journals such as The Journal of Immunology, Arteriosclerosis Thrombosis and Vascular Biology, Frontiers in Immunology, Frontiers in Pharmacology and Journal of Neuroinflammation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.